tirzepatide treatments silver spring md - 60mg Compounded Tirzepatide for Weight Loss
Description
This study was designed to assess the efficacy and safety of retatrutide across a range of doses over a 48-week treatment period, with a subsequent follow-up phase
That means the FDA has not reviewed them for safety or efficacy
Tirzepatide operates as a dual GIP and GLP-1 receptor agonist, making it a GLP-1 research peptide with expanded receptor reach
That assumption was wrong
